AU2001287022A1 - Secretory molecules - Google Patents

Secretory molecules

Info

Publication number: AU2001287022A1
Authority: AU; Australia
Prior art keywords: secretory molecules; secretory; molecules
Prior art date: 2000-09-05
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2001287022A

Inventor

Christina M. Altus

Alan P. Au

Diana L. Bradley

Michael S. Chalup

Simon C. Chang

Alice J. Chen

Abel Daffo

Christopher R. Dahl

Marie H. David

Gerard E. Dufour

Vincent Flores

Edward H. Gerstin

Darryl Gietzen

Bernard Harris

Rebekah R. Inman

Jennifer L. Jackson

Stuart E. Jackson

Anissa Lee Jones

Stephen E Lincoln

Tommy F. Liu

Rakesh Marwaha

Monika G. Momiyama

Scott R. Panzer

Careyna H. Peralta

Sameer D. Rohatgi

Ann M. Roseberry

Rachel J. Wright

Pierre E. Yap

Jimmy Y. Yu

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Incyte Corp

Original Assignee

Incyte Genomics Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-09-05

Filing date

2001-08-30

Publication date

2002-03-22

2001-08-30 Application filed by Incyte Genomics Inc filed Critical Incyte Genomics Inc

2002-03-22 Publication of AU2001287022A1 publication Critical patent/AU2001287022A1/en

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Zoology (AREA)
Genetics & Genomics (AREA)
Medicinal Chemistry (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Toxicology (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Peptides Or Proteins (AREA)
Investigating Or Analysing Biological Materials (AREA)

AU2001287022A 2000-09-05 2001-08-30 Secretory molecules Abandoned AU2001287022A1 (en)

Applications Claiming Priority (57)

Application Number	Priority Date	Filing Date	Title
US22975000P	2000-09-05	2000-09-05
US23058300P	2000-09-05	2000-09-05
US22975100P	2000-09-05	2000-09-05
US23001600P	2000-09-05	2000-09-05
US22974700P	2000-09-05	2000-09-05
US22974900P	2000-09-05	2000-09-05
US22974800P	2000-09-05	2000-09-05
US60/229,751		2000-09-05
US60/229,747		2000-09-05
US60/229,749		2000-09-05
US60/230,583		2000-09-05
US60/229,750		2000-09-05
US60/229,748		2000-09-05
US60/230,016		2000-09-05
US23051900P	2000-09-06	2000-09-06
US23086500P	2000-09-06	2000-09-06
US23086400P	2000-09-06	2000-09-06
US23059600P	2000-09-06	2000-09-06
US23098800P	2000-09-06	2000-09-06
US23050500P	2000-09-06	2000-09-06
US23099000P	2000-09-06	2000-09-06
US23059700P	2000-09-06	2000-09-06
US23051800P	2000-09-06	2000-09-06
US23059500P	2000-09-06	2000-09-06
US23098900P	2000-09-06	2000-09-06
US23051700P	2000-09-06	2000-09-06
US23059900P	2000-09-06	2000-09-06
US23061000P	2000-09-06	2000-09-06
US23051500P	2000-09-06	2000-09-06
US23051400P	2000-09-06	2000-09-06
US60/230,596		2000-09-06
US60/230,518		2000-09-06
US60/230,519		2000-09-06
US60/230,989		2000-09-06
US60/230,597		2000-09-06
US60/230,988		2000-09-06
US60/230,610		2000-09-06
US60/230,599		2000-09-06
US60/230,865		2000-09-06
US60/230,515		2000-09-06
US60/230,990		2000-09-06
US60/230,517		2000-09-06
US60/230,595		2000-09-06
US60/230,505		2000-09-06
US60/230,864		2000-09-06
US60/230,514		2000-09-06
US23089700P	2000-09-07	2000-09-07
US23089600P	2000-09-07	2000-09-07
US23183200P	2000-09-07	2000-09-07
US23116300P	2000-09-07	2000-09-07
US23095100P	2000-09-07	2000-09-07
US60/230,897		2000-09-07
US60/230,896		2000-09-07
US60/231,832		2000-09-07
US60/231,163		2000-09-07
US60/230,951		2000-09-07
PCT/US2001/027297 WO2002020756A2 (en)	2000-09-05	2001-08-30	Secretory molecules

Publications (1)

Publication Number	Publication Date
AU2001287022A1 true AU2001287022A1 (en)	2002-03-22

Family

ID=27586833

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2001287022A Abandoned AU2001287022A1 (en)	2000-09-05	2001-08-30	Secretory molecules

Country Status (4)

Country	Link
EP (1)	EP1368375A2 (en)
AU (1)	AU2001287022A1 (en)
CA (1)	CA2419943A1 (en)
WO (1)	WO2002020756A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1311675B1 (en)	2000-08-22	2007-02-07	Agensys, Inc.	Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers
US7358353B2 (en)	2000-08-22	2008-04-15	Agensys, Inc.	Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers
GB0027905D0 (en) *	2000-11-15	2000-12-27	Glaxo Group Ltd	New protein
AU2003215369A1 (en) *	2002-02-22	2003-09-09	Incyte Corporation	Intracellular signaling molecules
US7198899B2 (en)	2002-06-03	2007-04-03	Chiron Corporation	Use of NRG4, or inhibitors thereof, in the treatment of colon and pancreatic cancers
JP2004267015A (en) *	2003-03-05	2004-09-30	National Institute Of Advanced Industrial & Technology	Nucleic acid and canceration assay method using the nucleic acid
PL2887959T3 (en)	2012-08-23	2019-04-30	Agensys Inc	Antibody drug conjugates (adc) that bind to 158p1d7 proteins
CN110850088B (en) *	2019-12-06	2021-08-20	四川大学华西医院	Use of GTF2IRD2 autoantibody detection reagent in the preparation of lung cancer screening kit
JP2025528799A (en) *	2022-08-09	2025-09-02	ウィスコンシンアラムニリサーチファンデーション	Novel autoantibodies and methods for detecting Sjogren's disease

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2286303A1 (en) *	1997-04-08	1998-10-15	Human Genome Sciences, Inc.	20 human secreted proteins
AU2001236631A1 (en) *	2000-02-24	2001-09-03	Incyte Genomics, Inc.	Secretory molecules

2001
- 2001-08-30 AU AU2001287022A patent/AU2001287022A1/en not_active Abandoned
- 2001-08-30 EP EP01966516A patent/EP1368375A2/en not_active Withdrawn
- 2001-08-30 WO PCT/US2001/027297 patent/WO2002020756A2/en not_active Ceased
- 2001-08-30 CA CA002419943A patent/CA2419943A1/en not_active Abandoned

Also Published As

Publication number	Publication date
WO2002020756A2 (en)	2002-03-14
WO2002020756A3 (en)	2003-08-28
EP1368375A2 (en)	2003-12-10
CA2419943A1 (en)	2002-03-14

Publication	Publication Date	Title
AU2001246924A1 (en)	2001-11-07	Decoder
AU2001262847A1 (en)	2001-12-11	Language-understanding
AU2001292739A1 (en)	2002-04-08	1-oxorapamycins
AU2000267458A1 (en)	2001-10-15	Hypercomputer
AU2001254546A1 (en)	2001-11-07	Aminopiperidines
AU2001220246A1 (en)	2001-12-11	Neckphone
AU2001239310A1 (en)	2001-10-03	Decahydro-isoquinolines
AU2002236477A1 (en)	2002-06-03	Fgf-affinity chromatography
AU2001258349A1 (en)	2001-11-26	Bisacylguanidine
AU2001279754A1 (en)	2002-01-30	Indoloquinazolinones
AU2002245332A1 (en)	2002-08-12	Anergy-regulated molecules
AU2002337312A1 (en)	2003-05-06	Molecules
AU2001290931A1 (en)	2002-03-26	Ski-snowboard
AU2002311791A1 (en)	2002-10-28	Secretory molecules
AU2001285886A1 (en)	2002-03-22	2-guanidino-4-aryl-quinazoline
AU2001244470A1 (en)	2001-09-17	Assembly process
AU2001293852A1 (en)	2002-06-27	Sulfonylguanidine
AU2001258924A1 (en)	2001-11-26	Microsatellite-aflp
AU2001287022A1 (en)	2002-03-22	Secretory molecules
AU2001281921A1 (en)	2002-01-08	Bdellosomes
AU2001291876A1 (en)	2002-06-20	Triazolo-epothilones
AU2001246864A1 (en)	2002-01-10	Hypotensors
AU2001236631A1 (en)	2001-09-03	Secretory molecules
AU2001226668A1 (en)	2001-09-12	Crankshaft-starter-generator
AU2001284173A1 (en)	2002-03-04	Calycins

Legal Events

Date	Code	Title	Description
2004-01-22	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase